ChemicalBook > CAS DataBase List > Upadacitinib hemihydrate

Upadacitinib hemihydrate

Product Name
Upadacitinib hemihydrate
CAS No.
2050057-56-0
Chemical Name
Upadacitinib hemihydrate
Synonyms
Upadacitinib hemihydrate;ABT494 hemihydrate;ABT 494 hemihydrate;ABT-494 hemihydrate;Upadacitinib Hydrate;Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-";1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
CBNumber
CB29872273
Molecular Formula
C17H21F3N6O2
Formula Weight
398.39
MOL File
2050057-56-0.mol
More
Less

Upadacitinib hemihydrate Property

InChI
InChI=1/C17H19F3N6O.H2O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15;/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27);1H2/t10-,11+;/s3
InChIKey
VJSRYIXHEWRBKD-NFGOAHBONA-N
SMILES
C([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Upadacitinib hemihydrate Chemical Properties,Usage,Production

Clinical Use

RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Each prolonged-release tablet (RINVOQ 15 mg prolonged-release tablets.) contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.

Upadacitinib hemihydrate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Upadacitinib hemihydrate Suppliers

HANGZHOU KELAI BIOMEDICAL TECHNOLOGY Co., Ltd.
Tel
18957050573
Email
752803249@qq.com
Country
China
ProdList
248
Advantage
58
Taizhou Yuxin Biotechnology Co., Ltd.,
Tel
+86-0576--88902229 +86-13968687450
Email
yuxin@yuxchem.com
Country
China
ProdList
155
Advantage
58
Shandong Yuhe Pharmaceutical Technology Co., LTD
Tel
15263077727
Fax
QQ:2938966534
Email
1436425847@qq.com
Country
China
ProdList
164
Advantage
58
Jiangxi Zhiyan Biopharmaceutical Technology Co., Ltd
Tel
13732973797
Email
liu@zybiopharma.com
Country
China
ProdList
270
Advantage
58
Changzhou Borl Biotechnology Co.,LTD
Tel
13606124132;13656121842
Email
luyan0021@163.com
Country
China
ProdList
221
Advantage
58
Yunfei Pharmaceutical(Shenzhen) Co., Ltd.
Tel
0755-61160828 15994832653
Fax
0755-61160828
Email
hulixiu@yunfeipharma.com
Country
China
ProdList
249
Advantage
58
Suzhou Haijing Pharmaceutical Technology Co., Ltd
Tel
0512-62992936 17786580220
Email
2503890038@qq.com
Country
China
ProdList
90
Advantage
58
Hubei widely chemical technology Co., Ltd.
Tel
027-59402396 13419635609
Fax
027-83989310
Email
13419635609@163.com
Country
China
ProdList
1994
Advantage
55
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd
Tel
010-53679529 13801208576
Fax
010-64215766
Email
sales.2@chinazhongshuo.com
Country
China
ProdList
97
Advantage
65
Anhui Lianchuang Biological Medicine Co.,Ltd
Tel
0551-68779238 18056025720
Email
sales3@lcywhx.com
Country
China
ProdList
168
Advantage
57

2050057-56-0, Upadacitinib hemihydrateRelated Search:


  • 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
  • Upadacitinib hemihydrate
  • Upadacitinib Hydrate
  • Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-"
  • ABT 494 hemihydrate
  • ABT494 hemihydrate
  • ABT-494 hemihydrate
  • 2050057-56-0
  • API